Nonpeptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders (Q35937847)

11 August 2017

1 reference

title

Nonpeptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders (English)

1 reference

11 August 2017

3

George Chrousos

1 reference

11 August 2017

Carlo Contoreggi

1

1 reference

11 August 2017

Kenner C Rice

series ordinal

2

1 reference

11 August 2017

publication date

27 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

80

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

111-123

1 reference

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists

11 August 2017

cites work

1 reference

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

21 January 2018

1 reference

Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

21 January 2018

1 reference

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors

21 January 2018

1 reference

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

21 January 2018

1 reference

Involvement of rat lateral septum-acetylcholine pressor system in central amygdaloid nucleus-emotional pressor circuit

21 January 2018

1 reference

The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states

21 January 2018

1 reference

Clinical and biochemical evaluation of Cushing's syndrome

21 January 2018

1 reference

Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome

21 January 2018

1 reference

Lack of mutations of type 1 11beta-hydroxysteroid dehydrogenase gene in patients with abdominal obesity

21 January 2018

1 reference

NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress

21 January 2018

1 reference

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

21 January 2018

1 reference

Central and peripheral glucocorticoid receptor function in abdominal obesity

21 January 2018

1 reference

Rise in morning saliva cortisol is associated with abdominal obesity in men: A preliminary report

21 January 2018

1 reference

Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids

21 January 2018

1 reference

Insulin resistance and chronic cardiovascular inflammatory syndrome

21 January 2018

1 reference

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels

21 January 2018

1 reference

A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene-gene interaction

21 January 2018

1 reference

A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol

21 January 2018

1 reference

A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders

21 January 2018

1 reference

Insulin-sensitizing agents--thiazolidinediones (glitazones).

21 January 2018

1 reference

Safety of drugs commonly used to treat hypertension, dyslipidemia, and type 2 diabetes (the metabolic syndrome): part 1.

21 January 2018

1 reference

Neuroendocrine regulation of autoimmune/inflammatory disease

21 January 2018

1 reference

Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives

21 January 2018

1 reference

Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion

21 January 2018

1 reference

Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice

21 January 2018

1 reference

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents.

21 January 2018

1 reference

Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor

21 January 2018

1 reference

Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis.

21 January 2018

1 reference

Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine

21 January 2018

1 reference

Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis

21 January 2018

1 reference

Innervation of lymphoid organs and implications in development, aging, and autoimmunity

21 January 2018

1 reference

Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?

21 January 2018

1 reference

Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome

21 January 2018

1 reference

Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis

21 January 2018

1 reference

Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis

21 January 2018

1 reference

Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials

21 January 2018

1 reference

Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome

21 January 2018

1 reference

The autonomic nervous system in functional bowel disorders

21 January 2018

1 reference

Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in Fischer and Lewis rats

21 January 2018

1 reference

Central representation of bladder and colon revealed by dual transsynaptic tracing in the rat: substrates for pelvic visceral coordination

21 January 2018

1 reference

Convergent responses of Barrington's nucleus neurons to pelvic visceral stimuli in the rat: a juxtacellular labelling study

21 January 2018

1 reference

Role of Barrington's nucleus in the activation of rat locus coeruleus neurons by colonic distension

21 January 2018

1 reference

Peripheral corticotropin-releasing factor induces diarrhea in rats: role of CRF1 receptor in fecal watery excretion

21 January 2018

1 reference

Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats

21 January 2018

1 reference

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

21 January 2018

1 reference

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs

21 January 2018

1 reference

Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.

21 January 2018

1 reference

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons

21 January 2018

1 reference

Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming

21 January 2018

1 reference

Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice

21 January 2018

1 reference

Autoradiographic visualization of corticotropin releasing hormone type 1 receptors with a nonpeptide ligand: synthesis of [(76)Br]MJL-1-109-2.

21 January 2018

1 reference

The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000081785

1 reference

11 August 2017

1 reference